Healthcare Through Better Insight
Better treatment starts with more timely and more precise detection, at the very beginning.
As a fast-growing biotechnology company dedicated to inspiring a new state of health, we are committed to providing patients and healthcare providers with the innovative diagnostic and data tools needed to make better health decisions.
Our science-first approach to innovation ensures that our products are among the most effective, fast and affordable. Our INDICAID COVID-19 Rapid Antigen tests are EUA and available for both point-of-care and over the counter use.
Our proprietary technology, PHASIFY, redefines the gold standard of diagnostics by making target molecules quicker and easier to detect. The power of PHASIFY is being utilized in current product development as we continue to pioneer new diagnostics for other infectious diseases and cancer.
Our Product & Services
Introducing INDICAID health. We're helping people privately and safely test for many common conditions At-Home.
Our Focus Areas
Featured NewsAll News
Performance of the INDICAID COVID-19 Rapid Antigen Test Against Omicron Variant (B.1.1.529)
February 1, 2022
INDICAID COVID-19 Rapid Antigen Test Detects Omicron Variant B.1.1.529 & Sub-Variant BA.2 (B.1.1.529.2)
May 24, 2022
PHASE Scientific Donates 600 of its INDICAID COVID-19 Rapid Antigen At-Home Tests for CancerCon in Minneapolis June 9-12
May 20, 2022
Here’s How Long Some Popular At-Home Virus Test Kits Actually Last, According To The FDA
June 1, 2022
Greater cfDNA Recovery May Help Accelerate Development of Cancer Liquid Biopsy Applications
June 22, 2020
Kenya Grants Emergency Use Authorization for the INDICAID COVID-19 Rapid Antigen Test
August 30, 2021
PHASE Scientific Donates More than 2,000 INDICAID COVID-19 Tests to Atlanta Public Schools Back to School Bash
July 27, 2022
PHASE Scientific Americas and Dr. B Partner to Make It Easier Than Ever To Test-To-Treat COVID-19 At Home
December 21, 2022
The Diagnostic Partner: Expanding The Use of Test-to-Treat in the Post-pandemic World
February 21, 2023
INDICAID COVID-19 Rapid Antigen Test Receives Emergency Use Authorization From the U.S. Food and Drug Administration
August 11, 2021